Zimmer Biomet Holdings Inc (ZBH)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $19.53B
Last updated: Nov 17, 2026 at 11:06 AM ET
Zimmer Biomet Holdings Inc (ZBH) P/E Ratio & Valuation History
Zimmer Biomet Holdings (ZBH) trades at 12.0x trailing earnings and 2.3x sales. Its P/E of 12.0x is below its 5-year median of 14.7x. Its forward P/E is 11.4x. The median P/E across 9 similar companies is 21.9x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 5.3% higher over the next year. Its free cash flow yield is 8.5%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 12.0x |
| Forward P/E | 11.4x |
| Price to sales | 2.3x |
| Price to book | 1.5x |
| EV/EBITDA | 11.6x |
| Price to FCF | 11.8x |
| EV/FCF | 16.1x |
| PEG | 2.2 |
| FCF yield | 8.5% |
Historical Medians
Against its 10-year medians, its P/E is 22.6% below 15.5x, its P/S is 28.1% below 3.2x and its P/B is 28.6% below 2.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 12.0x | 14.7x | 15.5x |
| P/S | 2.3x | 3.2x | 3.2x |
| P/B | 1.5x | 1.8x | 2.1x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 11.0x in 2025 to 27.2x in 2020. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $89.92 | 11.0x | 2.2x | 1.4x |
| 2024 | $105.63 | 13.2x | 2.8x | 1.7x |
| 2023 | $121.70 | 16.1x | 3.4x | 2.0x |
| 2022 | $127.50 | 18.5x | 3.9x | 2.2x |
| 2021 | $127.04 | 17.2x | 3.9x | 2.1x |
| 2020 | $154.09 | 27.2x | 5.2x | 2.6x |
| 2019 | $149.68 | 19.0x | 3.9x | 2.5x |
| 2018 | $103.72 | 13.6x | 2.7x | 1.9x |
| 2017 | $120.67 | 15.0x | 3.1x | 2.1x |
| 2016 | $103.20 | 13.0x | 2.7x | 2.2x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ZBH
What is ZBH's forward P/E ratio?
Zimmer Biomet Holdings has a forward P/E ratio of 11.4x.
Is ZBH stock overvalued?
GNG's valuation label for ZBH is Undervalued. Its P/E of 12.0x compares with a median of 21.9x across 9 similar companies.
What is ZBH's price to sales ratio?
Zimmer Biomet Holdings has a price to sales ratio of 2.3x.
What is Zimmer Biomet Holdings's average P/E ratio over 5 years?
Zimmer Biomet Holdings's median P/E over the last 5 years is 14.7x, from 60 month-end values through Oct 2026.
What is ZBH's PEG ratio?
Zimmer Biomet Holdings has a PEG ratio of 2.2.
ZBH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts